Search

everythinglearnresearchcommunity

for

Search:↓

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Hormone treatments can help with women's skin and hair disorders, but they need careful monitoring and more research.

Most treatments for spondyloarthritis are safe, but monitoring and careful selection based on patient risks are important.

Acne is a chronic skin condition not caused by poor hygiene or diet, and it requires long-term treatment and patient education.

The document concludes that early diagnosis and treatment are key for pediatric hair loss disorders, and addressing the emotional effects on children is important.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Low-level light therapy, possibly combined with other treatments, may become a leading hair loss treatment, while hirsutism often worsens with age and lacks preventive options.

Hidradenitis Suppurativa is likely an autoinflammatory disease, and better understanding its causes could improve treatments.

Testosterone therapy can help postmenopausal women with low sexual desire but needs more safety research and should be used with estrogen therapy.

5-Alpha Reductase Inhibitors are effective for male hair loss and some skin conditions, but their effectiveness in women and safety concerns require careful use.

Light therapy with various colors helps treat hair loss.

Stem cell and platelet-rich plasma therapies show promise for COVID-19 related hair loss, but more research is needed.

Finasteride, a hair loss drug, can cause sexual side effects like erectile dysfunction in 2.1%-3.8% of users, but these usually go away with time or if the drug is stopped. Despite this, its impact on sexual function is minimal for most men.

Cryotherapy helps reduce chemotherapy side effects but needs more research for best use.

PRP treatments have shown mixed results for healing, and future research should focus on how PRP is used and which type is used.

Platelet-Rich Plasma (PRP) has potential benefits in plastic surgery, especially for skin grafts, wound healing, hair loss, mild Carpal Tunnel Syndrome, and TMJ disorders, but more research is needed to confirm its effectiveness.

JAK-inhibitors for alopecia areata are generally safe with mostly mild side effects and a low rate of treatment withdrawal.

Topical minoxidil is the best-supported treatment for female hair loss, but personalized plans are needed.

Budesonide is not effective for maintaining remission in Crohn's disease beyond three months.

Fractional lasers effectively treat alopecia areata, especially when combined with minoxidil or cortisol.

Stem cell therapies show promise for hair regrowth but need more research to confirm effectiveness.

There is no cure for alopecia areata, but treatments like JAK inhibitors show promise.

Shorter telomeres in white blood cells may increase the risk of a common type of hair loss.

Latisse (bimatoprost 0.03%) is widely used in dermatology but the document doesn't give detailed evidence or numbers.

Medications for glucose metabolism and weight control, combined therapy options, and herbal medicines may help regulate menstrual cycle in adolescents with PCOS.

PRP is promising for skin, hair, and wound treatments but needs standardized methods and more research.

More oxygen isn't always better and can sometimes be worse.

Gender-affirming hormone therapy improves physical performance in trans men to the level of cisgender men, while in trans women, it increases fat mass and decreases muscle mass, with no advantage in physical performance after 2 years.

Androgens are important for female fertility and could help in IVF treatment, but also play a role in causing PCOS.

rTMS may help treat trichotillomania in some patients.